N-Substituted 1H-Pyrimidin-4-One Derivatives Possessing Anxiolytic Activity


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The logical framework approach was implemented for designing CNS-active N-substituted 1H-pyrimidin-4-ones. Formation energies of possible ligand—receptor complexes with D2-dopamine and GABAA Receptors were determined from molecular docking calculations. The results allowed the probability of psychotropic activity manifesting in the modeled compounds to be estimated. The most promising compounds were prepared by a modified synthetic procedure. The effect of the heteroatom type in N-heterocyclic 1H-pyrimidin-4-ones on the product yield was studied. Compounds IIV and VI at a dose of 50 mg/kg exhibited anticonflict activity. The mercaptotriazole derivative of pyrimidin-4-one had the greatest anticonflict activity.

Авторлар туралы

É. Oganesyan

Pyatigorsk Medical Pharmaceutical Institute, Branch of Volga State Medical University, Ministry of Health of Russia

Хат алмасуға жауапты Автор.
Email: edwardov@mail.ru
Ресей, 11 Prosp. Kalinina, Pyatigorsk, 357532

I. Kodonidi

Pyatigorsk Medical Pharmaceutical Institute, Branch of Volga State Medical University, Ministry of Health of Russia

Email: edwardov@mail.ru
Ресей, 11 Prosp. Kalinina, Pyatigorsk, 357532

A. Bandura

Pyatigorsk Medical Pharmaceutical Institute, Branch of Volga State Medical University, Ministry of Health of Russia

Email: edwardov@mail.ru
Ресей, 11 Prosp. Kalinina, Pyatigorsk, 357532

V. Sochnev

Pyatigorsk Medical Pharmaceutical Institute, Branch of Volga State Medical University, Ministry of Health of Russia

Email: edwardov@mail.ru
Ресей, 11 Prosp. Kalinina, Pyatigorsk, 357532

É. Manvelyan

North-Caucasus Federal University

Email: edwardov@mail.ru
Ресей, 1 Pushkin St., Stavropol, 355009

V. Sysa

North-Caucasus Federal University

Email: edwardov@mail.ru
Ресей, 1 Pushkin St., Stavropol, 355009

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media, LLC, 2017